IngentaConnect A long-term time course of colorimetric assessment of the effects...

Authors: Brazzelli, V; Prestinari, F¹; Barbagallo, T¹; Rona, C¹; Orlandi, E²; Passamonti, F²; Locatelli, F³; Zecca, M³; Villani, S⁴; Borroni, G¹

Source: Journal of the European Academy of Dermatology & Venereology, Volume 21, Number 3, March 2007 , pp. 384-387(4)

Publisher: Blackwell Publishing

Abstract:

Background

Imatinib mesylate (IM), the first-line treatment of chronic myeloid leukaemia (CML), is a tyrosine kinase inhibitor that targets those proteins involved in BCR-ABL signal transduction in CML, c-kit (KIT) and platelet-derived growth-factor (PDGFR) receptor. The use of IM has been associated with cutaneous reactions. In the last 2 years numerous studies have focused the attention on hypopigmentations, depigmentations and photosensitivity developing after the initiation of IM therapy. Objective

The aim of this study is to evaluate the effects of IM therapy on the skin pigmentation of five patients affected by CML. Methods

Skin pigmentation measurements were performed with a Minolta CR-200 Chromameter. Results

All the studied patients show the gradual lightening of the skin on unexposed areas over the treatment with IM. In particular, this explorative colorimetric study indicates the association between IM and skin depigmentation with a significant increase of luminance value (L*) (P = 0.001) and a significant decrease of the pigmentation value (b*) (P = 0.028). Conclusion

Even if we do not know the clinical significance of the skin depigmentation caused by IM, the regulatory role of KIT and its ligand stem cell factor in melanocyte development and survival seems to suggest an objective mechanism of action for IM in the pathogenesis of this cutaneous depigmentation.

Keywords: chronic myeloid leukaemia; colorimetry; hypopigmentation; imatinib mesylate

Document Type: Research article

DOI: 10.1111/j.1468-3083.2006.01981.x

Affiliations: 1: Department of Human and Hereditary Pathology, Institute of Dermatology, 2: Institute of Hematology, 3: Department of Pediatrics, 4: Department of Health Sciences, Section of Medical Statistics and Epidemiology, University of Pavia, Policlinico S. Matteo IRCCS, Pavia, Italy

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.39 plus tax Refund Policy

A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients